pearsons correlation analysis Search Results


90
MedCalc Software Ltd pearson correlation and regression analysis
Pearson Correlation And Regression Analysis, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pmc04557910-199-3-8?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
pearson correlation and regression analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
RStudio pearson’s correlation analysis
Pearson’s Correlation Analysis, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pmc09357907-65-8-15?v=RStudio
Average 90 stars, based on 1 article reviews
pearson’s correlation analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Addinsoft inc pearson correlation matrix and principal component analysis
Pearson Correlation Matrix And Principal Component Analysis, supplied by Addinsoft inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pm37050182-402-14-1?v=Addinsoft+inc
Average 90 stars, based on 1 article reviews
pearson correlation matrix and principal component analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
DuPont de Nemours pearson’s rank correlation
Pearson’s Rank Correlation, supplied by DuPont de Nemours, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pm31662247-146-15-22?v=DuPont+de+Nemours
Average 90 stars, based on 1 article reviews
pearson’s rank correlation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriginLab corp pearson correlation
Pearson Correlation, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pmc03337852-102-5-8?v=OriginLab+corp
Average 90 stars, based on 1 article reviews
pearson correlation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Federation of European Neuroscience Societies correlogram analysis
Correlogram Analysis, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pm18363704-146-2-12?v=Federation+of+European+Neuroscience+Societies
Average 90 stars, based on 1 article reviews
correlogram analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriginLab corp pearson's correlation (two-tailed) and principal component analysis (pca) biplot analysis
<t> Pearson 's correlation </t> between recorded parameters under control conditions. * Significant at P <0.05 and ** significant at P <0.01. C i / C a – the ratio of intercellular to ambient CO 2 concentration; E – transpiration rate; F v /F m – maximal quantum efficiency of PSII; g H2O – water vapor conductance; MDA – malondialdehyde; NPQ – nonphotochemical quenching; P N – net assimilation rate; TAOC – total antioxidant capacity; VPD – air to leaf vapor pressure deficit; Y NPQ – quantum yield of NPQ-related energy loss; Ф PSII – quantum yield of photosynthetic electron transport.
Pearson's Correlation (Two Tailed) And Principal Component Analysis (Pca) Biplot Analysis, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pmc11558602-151-0-24?v=OriginLab+corp
Average 90 stars, based on 1 article reviews
pearson's correlation (two-tailed) and principal component analysis (pca) biplot analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CH Instruments square test/fisher’s exact test and pearson correlation analysis
<t> Pearson 's correlation </t> between recorded parameters under control conditions. * Significant at P <0.05 and ** significant at P <0.01. C i / C a – the ratio of intercellular to ambient CO 2 concentration; E – transpiration rate; F v /F m – maximal quantum efficiency of PSII; g H2O – water vapor conductance; MDA – malondialdehyde; NPQ – nonphotochemical quenching; P N – net assimilation rate; TAOC – total antioxidant capacity; VPD – air to leaf vapor pressure deficit; Y NPQ – quantum yield of NPQ-related energy loss; Ф PSII – quantum yield of photosynthetic electron transport.
Square Test/Fisher’s Exact Test And Pearson Correlation Analysis, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pm37345605-78-28-22?v=CH+Instruments
Average 90 stars, based on 1 article reviews
square test/fisher’s exact test and pearson correlation analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
statpoint inc pearson correlation analysis
<t> Pearson 's correlation </t> between recorded parameters under control conditions. * Significant at P <0.05 and ** significant at P <0.01. C i / C a – the ratio of intercellular to ambient CO 2 concentration; E – transpiration rate; F v /F m – maximal quantum efficiency of PSII; g H2O – water vapor conductance; MDA – malondialdehyde; NPQ – nonphotochemical quenching; P N – net assimilation rate; TAOC – total antioxidant capacity; VPD – air to leaf vapor pressure deficit; Y NPQ – quantum yield of NPQ-related energy loss; Ф PSII – quantum yield of photosynthetic electron transport.
Pearson Correlation Analysis, supplied by statpoint inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pm36230171-56-8-14?v=statpoint+inc
Average 90 stars, based on 1 article reviews
pearson correlation analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
RStudio custom code for pearson’s correlation analysis
a-c, WT or lilrb4 -KO THP-1 cells (3×10 6 cells/mouse) were subcutaneously implanted into hPBMC-repopulated NSG mice (WT, n=14 mice with mean and s.e.m.; lilrb4 -KO, n=10 mice with mean and s.e.m. Also see Source Data .). Shown are tumor size ( a ), quantitation of CD3 + at day 31 in peripheral blood of recipient mice ( b ) and representative flow plots showing CD4 + and CD8 + T cells ( c ). d-e, LILRB4 increases PD-1 expression on tumor-infiltrated T cells. WT or lilrb4 -KO THP-1 cells were subcutaneously implanted into hPBMC-repopulated NSG mice. Three weeks after implantation, 7 out of 10 WT-group mice had large tumors and 3 out of 10 KO-group mice had tiny tumors. These tumors were dissected for immunohistochemistry and flow cytometry staining with anti-LILRB4, anti-CD3, anti-PD-1 or anti-Arginase-1 antibodies. Left corner images were magnified from the yellow highlighted regions. In CD3 and PD-1 staining images, orange dash lines indicate the tumor boundary. Black arrowheads indicate PD-1 positive cells. Scale bar, 100 μm. Shown in e , tumors were dissected and cells in tumor region were stained with anti-CD3 and anti-PD-1 antibodies for flow cytometry analysis. The percentages of PD-1 + T cells (Ratio of PD-1 + CD3 + cells/CD3 + cells) were calculated. f-i, THP-1 cells were transplanted into hPBMC-repopulated NSG mice, and mice were treated with control IgG or anti-LILRB4 antibody after 6 days (10 mg/kg; n=5). Leukemia development was monitored by luminescence imaging ( f ); luminescence flux (radiance) at day 26 ( g ; n=5) and T cell numbers at day 26 in representative mice ( h-i ) were also shown. j-k, Engraftment of human T cells and i.v. transplanted Doxycycline (Dox)-inducible lilrb4 -knockout THP-1 cells (GFP + ) in NSG mice at day 7 before Dox administration (n=5). l, Representative flow plot shows LILRB4 was successfully deleted in engrafted leukemia cells in bone marrow of Dox-fed mouse at the endpoint. n.s., not significant. m-w, Mouse AML C1498 cells (3×10 6 cells/mouse) that stably express LILRB4-IRES-GFP were s.c. implanted into C57bl/6 mice. Anti-LILRB4-N297A antibodies or control IgG were i.v. injected at 6, 9, 12, 15, 18, and 21 days post implantation of tumor cells. Two groups of mice were treated with anti-CD8 antibodies at 3, 6, 9, and 12 days post implantation of tumor cells to achieve CD8 + T cell depletion. m, Tumor growth of subcutaneously implanted human LILRB4-expressing mouse AML C1498 cells (h lilrb4 -C1498) in C57BL/6 mice with anti-LILRB4-N297A antibody or control antibody treatment (n=5 mice). Also see Source Data . n, Survival curve of subcutaneous h lilrb4 -C1498-tumor-bearing mice (n=12 mice). Same as tumor size, anti-LILRB4 antibodies decreased the tumor weight ( o, n=5 mice) but did not in the absence of CD8 + T cells ( p, n=5 mice). The percentage of CD8 + T cells in spleen is significantly negatively correlated with tumor size ( q, n=5 mice) but not in the absence of CD8 + T cells ( r, n=5 mice). s, Adoptive transplantation of spleen cells from control mice or tumor-bearing mice that were cured by anti-LILRB4-N297A treatment (n=5 mice). Tumor size was monitored as a function of time. Arrow indicates day of rechallenge in mice that had eliminated leukemia with 3-times number of AML cells (n=4 mice). Also see Source Data . Anti-LILRB4 antibodies reduced the leukemia cells infiltrating into host tissues ( t-v, n=5 mice ) and even CD8 + cells were depleted ( w, n=5 mice). x-z, C57bl/6 mice were i.v. implanted with human LILRb4-expressing mouse AML C1498 cells (3×10 6 cells/mouse) that express GFP. Anti-LILRB4-N297A antibodies (n=9 mice) or control IgG (n=9 mice) were i.v. injected at 6, 9, 12, 15 and 18 days post implantation of tumor cells. Anti-LILRB4 antibodies decreased the percentage of leukemia cells in bone marrow ( x ). Anti-LILRB4 antibodies increased CD8 + T cells ( y ). The percentage of CD8 + T cells in bone marrow is significantly negatively correlated with the percentage of leukemia cells ( z ). ( c, i and l ) These experiments were repeated independently three times with similar results. See for definition of box plot elements in b, e, g-h, j-k, o-p and t-y . All p values (except of n from long-rank test; and except of q-r and z from <t>Pearson’s</t> correlation) were from two-tailed student t -test.
Custom Code For Pearson’s Correlation Analysis, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pmc06296374-201-4-8?v=RStudio
Average 90 stars, based on 1 article reviews
custom code for pearson’s correlation analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
RStudio pearson’s correlation analysis rstudio corr.test function using “pearson” method
a-c, WT or lilrb4 -KO THP-1 cells (3×10 6 cells/mouse) were subcutaneously implanted into hPBMC-repopulated NSG mice (WT, n=14 mice with mean and s.e.m.; lilrb4 -KO, n=10 mice with mean and s.e.m. Also see Source Data .). Shown are tumor size ( a ), quantitation of CD3 + at day 31 in peripheral blood of recipient mice ( b ) and representative flow plots showing CD4 + and CD8 + T cells ( c ). d-e, LILRB4 increases PD-1 expression on tumor-infiltrated T cells. WT or lilrb4 -KO THP-1 cells were subcutaneously implanted into hPBMC-repopulated NSG mice. Three weeks after implantation, 7 out of 10 WT-group mice had large tumors and 3 out of 10 KO-group mice had tiny tumors. These tumors were dissected for immunohistochemistry and flow cytometry staining with anti-LILRB4, anti-CD3, anti-PD-1 or anti-Arginase-1 antibodies. Left corner images were magnified from the yellow highlighted regions. In CD3 and PD-1 staining images, orange dash lines indicate the tumor boundary. Black arrowheads indicate PD-1 positive cells. Scale bar, 100 μm. Shown in e , tumors were dissected and cells in tumor region were stained with anti-CD3 and anti-PD-1 antibodies for flow cytometry analysis. The percentages of PD-1 + T cells (Ratio of PD-1 + CD3 + cells/CD3 + cells) were calculated. f-i, THP-1 cells were transplanted into hPBMC-repopulated NSG mice, and mice were treated with control IgG or anti-LILRB4 antibody after 6 days (10 mg/kg; n=5). Leukemia development was monitored by luminescence imaging ( f ); luminescence flux (radiance) at day 26 ( g ; n=5) and T cell numbers at day 26 in representative mice ( h-i ) were also shown. j-k, Engraftment of human T cells and i.v. transplanted Doxycycline (Dox)-inducible lilrb4 -knockout THP-1 cells (GFP + ) in NSG mice at day 7 before Dox administration (n=5). l, Representative flow plot shows LILRB4 was successfully deleted in engrafted leukemia cells in bone marrow of Dox-fed mouse at the endpoint. n.s., not significant. m-w, Mouse AML C1498 cells (3×10 6 cells/mouse) that stably express LILRB4-IRES-GFP were s.c. implanted into C57bl/6 mice. Anti-LILRB4-N297A antibodies or control IgG were i.v. injected at 6, 9, 12, 15, 18, and 21 days post implantation of tumor cells. Two groups of mice were treated with anti-CD8 antibodies at 3, 6, 9, and 12 days post implantation of tumor cells to achieve CD8 + T cell depletion. m, Tumor growth of subcutaneously implanted human LILRB4-expressing mouse AML C1498 cells (h lilrb4 -C1498) in C57BL/6 mice with anti-LILRB4-N297A antibody or control antibody treatment (n=5 mice). Also see Source Data . n, Survival curve of subcutaneous h lilrb4 -C1498-tumor-bearing mice (n=12 mice). Same as tumor size, anti-LILRB4 antibodies decreased the tumor weight ( o, n=5 mice) but did not in the absence of CD8 + T cells ( p, n=5 mice). The percentage of CD8 + T cells in spleen is significantly negatively correlated with tumor size ( q, n=5 mice) but not in the absence of CD8 + T cells ( r, n=5 mice). s, Adoptive transplantation of spleen cells from control mice or tumor-bearing mice that were cured by anti-LILRB4-N297A treatment (n=5 mice). Tumor size was monitored as a function of time. Arrow indicates day of rechallenge in mice that had eliminated leukemia with 3-times number of AML cells (n=4 mice). Also see Source Data . Anti-LILRB4 antibodies reduced the leukemia cells infiltrating into host tissues ( t-v, n=5 mice ) and even CD8 + cells were depleted ( w, n=5 mice). x-z, C57bl/6 mice were i.v. implanted with human LILRb4-expressing mouse AML C1498 cells (3×10 6 cells/mouse) that express GFP. Anti-LILRB4-N297A antibodies (n=9 mice) or control IgG (n=9 mice) were i.v. injected at 6, 9, 12, 15 and 18 days post implantation of tumor cells. Anti-LILRB4 antibodies decreased the percentage of leukemia cells in bone marrow ( x ). Anti-LILRB4 antibodies increased CD8 + T cells ( y ). The percentage of CD8 + T cells in bone marrow is significantly negatively correlated with the percentage of leukemia cells ( z ). ( c, i and l ) These experiments were repeated independently three times with similar results. See for definition of box plot elements in b, e, g-h, j-k, o-p and t-y . All p values (except of n from long-rank test; and except of q-r and z from <t>Pearson’s</t> correlation) were from two-tailed student t -test.
Pearson’s Correlation Analysis Rstudio Corr.Test Function Using “Pearson” Method, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pm40181190-122-8-10?v=RStudio
Average 90 stars, based on 1 article reviews
pearson’s correlation analysis rstudio corr.test function using “pearson” method - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriginLab corp pearson correlation analysis origin 9.0
a-c, WT or lilrb4 -KO THP-1 cells (3×10 6 cells/mouse) were subcutaneously implanted into hPBMC-repopulated NSG mice (WT, n=14 mice with mean and s.e.m.; lilrb4 -KO, n=10 mice with mean and s.e.m. Also see Source Data .). Shown are tumor size ( a ), quantitation of CD3 + at day 31 in peripheral blood of recipient mice ( b ) and representative flow plots showing CD4 + and CD8 + T cells ( c ). d-e, LILRB4 increases PD-1 expression on tumor-infiltrated T cells. WT or lilrb4 -KO THP-1 cells were subcutaneously implanted into hPBMC-repopulated NSG mice. Three weeks after implantation, 7 out of 10 WT-group mice had large tumors and 3 out of 10 KO-group mice had tiny tumors. These tumors were dissected for immunohistochemistry and flow cytometry staining with anti-LILRB4, anti-CD3, anti-PD-1 or anti-Arginase-1 antibodies. Left corner images were magnified from the yellow highlighted regions. In CD3 and PD-1 staining images, orange dash lines indicate the tumor boundary. Black arrowheads indicate PD-1 positive cells. Scale bar, 100 μm. Shown in e , tumors were dissected and cells in tumor region were stained with anti-CD3 and anti-PD-1 antibodies for flow cytometry analysis. The percentages of PD-1 + T cells (Ratio of PD-1 + CD3 + cells/CD3 + cells) were calculated. f-i, THP-1 cells were transplanted into hPBMC-repopulated NSG mice, and mice were treated with control IgG or anti-LILRB4 antibody after 6 days (10 mg/kg; n=5). Leukemia development was monitored by luminescence imaging ( f ); luminescence flux (radiance) at day 26 ( g ; n=5) and T cell numbers at day 26 in representative mice ( h-i ) were also shown. j-k, Engraftment of human T cells and i.v. transplanted Doxycycline (Dox)-inducible lilrb4 -knockout THP-1 cells (GFP + ) in NSG mice at day 7 before Dox administration (n=5). l, Representative flow plot shows LILRB4 was successfully deleted in engrafted leukemia cells in bone marrow of Dox-fed mouse at the endpoint. n.s., not significant. m-w, Mouse AML C1498 cells (3×10 6 cells/mouse) that stably express LILRB4-IRES-GFP were s.c. implanted into C57bl/6 mice. Anti-LILRB4-N297A antibodies or control IgG were i.v. injected at 6, 9, 12, 15, 18, and 21 days post implantation of tumor cells. Two groups of mice were treated with anti-CD8 antibodies at 3, 6, 9, and 12 days post implantation of tumor cells to achieve CD8 + T cell depletion. m, Tumor growth of subcutaneously implanted human LILRB4-expressing mouse AML C1498 cells (h lilrb4 -C1498) in C57BL/6 mice with anti-LILRB4-N297A antibody or control antibody treatment (n=5 mice). Also see Source Data . n, Survival curve of subcutaneous h lilrb4 -C1498-tumor-bearing mice (n=12 mice). Same as tumor size, anti-LILRB4 antibodies decreased the tumor weight ( o, n=5 mice) but did not in the absence of CD8 + T cells ( p, n=5 mice). The percentage of CD8 + T cells in spleen is significantly negatively correlated with tumor size ( q, n=5 mice) but not in the absence of CD8 + T cells ( r, n=5 mice). s, Adoptive transplantation of spleen cells from control mice or tumor-bearing mice that were cured by anti-LILRB4-N297A treatment (n=5 mice). Tumor size was monitored as a function of time. Arrow indicates day of rechallenge in mice that had eliminated leukemia with 3-times number of AML cells (n=4 mice). Also see Source Data . Anti-LILRB4 antibodies reduced the leukemia cells infiltrating into host tissues ( t-v, n=5 mice ) and even CD8 + cells were depleted ( w, n=5 mice). x-z, C57bl/6 mice were i.v. implanted with human LILRb4-expressing mouse AML C1498 cells (3×10 6 cells/mouse) that express GFP. Anti-LILRB4-N297A antibodies (n=9 mice) or control IgG (n=9 mice) were i.v. injected at 6, 9, 12, 15 and 18 days post implantation of tumor cells. Anti-LILRB4 antibodies decreased the percentage of leukemia cells in bone marrow ( x ). Anti-LILRB4 antibodies increased CD8 + T cells ( y ). The percentage of CD8 + T cells in bone marrow is significantly negatively correlated with the percentage of leukemia cells ( z ). ( c, i and l ) These experiments were repeated independently three times with similar results. See for definition of box plot elements in b, e, g-h, j-k, o-p and t-y . All p values (except of n from long-rank test; and except of q-r and z from <t>Pearson’s</t> correlation) were from two-tailed student t -test.
Pearson Correlation Analysis Origin 9.0, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearsons+correlation+analysis/pmc08461334-65-5-22?v=OriginLab+corp
Average 90 stars, based on 1 article reviews
pearson correlation analysis origin 9.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


 Pearson 's correlation  between recorded parameters under control conditions. * Significant at P <0.05 and ** significant at P <0.01. C i / C a – the ratio of intercellular to ambient CO 2 concentration; E – transpiration rate; F v /F m – maximal quantum efficiency of PSII; g H2O – water vapor conductance; MDA – malondialdehyde; NPQ – nonphotochemical quenching; P N – net assimilation rate; TAOC – total antioxidant capacity; VPD – air to leaf vapor pressure deficit; Y NPQ – quantum yield of NPQ-related energy loss; Ф PSII – quantum yield of photosynthetic electron transport.

Journal: Photosynthetica

Article Title: Biochemical, gas exchange, and chlorophyll fluorescence analysis of maize genotypes under drought stress reveals important insights into their interaction and homeostasis

doi: 10.32615/ps.2022.024

Figure Lengend Snippet: Pearson 's correlation between recorded parameters under control conditions. * Significant at P <0.05 and ** significant at P <0.01. C i / C a – the ratio of intercellular to ambient CO 2 concentration; E – transpiration rate; F v /F m – maximal quantum efficiency of PSII; g H2O – water vapor conductance; MDA – malondialdehyde; NPQ – nonphotochemical quenching; P N – net assimilation rate; TAOC – total antioxidant capacity; VPD – air to leaf vapor pressure deficit; Y NPQ – quantum yield of NPQ-related energy loss; Ф PSII – quantum yield of photosynthetic electron transport.

Article Snippet: Pearson 's correlation (two-tailed) and principal component analysis (PCA) biplot analysis for both genotypes and recorded parameters was performed in Origin Pro 2022 ( https://www.originlab.com/ ).

Techniques: Control, Concentration Assay, Multiple Displacement Amplification

 Pearson 's correlation  between recorded parameters under drought. * Significant at P <0.05 and ** significant at P <0.01. C i / C a – the ratio of intercellular to ambient CO 2 concentration; E – transpiration rate; F v /F m – maximal quantum efficiency of PSII; g H2O – water vapor conductance; MDA – malondialdehyde; NPQ – nonphotochemical quenching; P N – net assimilation rate; TAOC – total antioxidant capacity; VPD – air to leaf vapor pressure deficit; Y NPQ – quantum yield of NPQ-related energy loss; Ф PSII – quantum yield of photosynthetic electron transport.

Journal: Photosynthetica

Article Title: Biochemical, gas exchange, and chlorophyll fluorescence analysis of maize genotypes under drought stress reveals important insights into their interaction and homeostasis

doi: 10.32615/ps.2022.024

Figure Lengend Snippet: Pearson 's correlation between recorded parameters under drought. * Significant at P <0.05 and ** significant at P <0.01. C i / C a – the ratio of intercellular to ambient CO 2 concentration; E – transpiration rate; F v /F m – maximal quantum efficiency of PSII; g H2O – water vapor conductance; MDA – malondialdehyde; NPQ – nonphotochemical quenching; P N – net assimilation rate; TAOC – total antioxidant capacity; VPD – air to leaf vapor pressure deficit; Y NPQ – quantum yield of NPQ-related energy loss; Ф PSII – quantum yield of photosynthetic electron transport.

Article Snippet: Pearson 's correlation (two-tailed) and principal component analysis (PCA) biplot analysis for both genotypes and recorded parameters was performed in Origin Pro 2022 ( https://www.originlab.com/ ).

Techniques: Concentration Assay, Multiple Displacement Amplification

a-c, WT or lilrb4 -KO THP-1 cells (3×10 6 cells/mouse) were subcutaneously implanted into hPBMC-repopulated NSG mice (WT, n=14 mice with mean and s.e.m.; lilrb4 -KO, n=10 mice with mean and s.e.m. Also see Source Data .). Shown are tumor size ( a ), quantitation of CD3 + at day 31 in peripheral blood of recipient mice ( b ) and representative flow plots showing CD4 + and CD8 + T cells ( c ). d-e, LILRB4 increases PD-1 expression on tumor-infiltrated T cells. WT or lilrb4 -KO THP-1 cells were subcutaneously implanted into hPBMC-repopulated NSG mice. Three weeks after implantation, 7 out of 10 WT-group mice had large tumors and 3 out of 10 KO-group mice had tiny tumors. These tumors were dissected for immunohistochemistry and flow cytometry staining with anti-LILRB4, anti-CD3, anti-PD-1 or anti-Arginase-1 antibodies. Left corner images were magnified from the yellow highlighted regions. In CD3 and PD-1 staining images, orange dash lines indicate the tumor boundary. Black arrowheads indicate PD-1 positive cells. Scale bar, 100 μm. Shown in e , tumors were dissected and cells in tumor region were stained with anti-CD3 and anti-PD-1 antibodies for flow cytometry analysis. The percentages of PD-1 + T cells (Ratio of PD-1 + CD3 + cells/CD3 + cells) were calculated. f-i, THP-1 cells were transplanted into hPBMC-repopulated NSG mice, and mice were treated with control IgG or anti-LILRB4 antibody after 6 days (10 mg/kg; n=5). Leukemia development was monitored by luminescence imaging ( f ); luminescence flux (radiance) at day 26 ( g ; n=5) and T cell numbers at day 26 in representative mice ( h-i ) were also shown. j-k, Engraftment of human T cells and i.v. transplanted Doxycycline (Dox)-inducible lilrb4 -knockout THP-1 cells (GFP + ) in NSG mice at day 7 before Dox administration (n=5). l, Representative flow plot shows LILRB4 was successfully deleted in engrafted leukemia cells in bone marrow of Dox-fed mouse at the endpoint. n.s., not significant. m-w, Mouse AML C1498 cells (3×10 6 cells/mouse) that stably express LILRB4-IRES-GFP were s.c. implanted into C57bl/6 mice. Anti-LILRB4-N297A antibodies or control IgG were i.v. injected at 6, 9, 12, 15, 18, and 21 days post implantation of tumor cells. Two groups of mice were treated with anti-CD8 antibodies at 3, 6, 9, and 12 days post implantation of tumor cells to achieve CD8 + T cell depletion. m, Tumor growth of subcutaneously implanted human LILRB4-expressing mouse AML C1498 cells (h lilrb4 -C1498) in C57BL/6 mice with anti-LILRB4-N297A antibody or control antibody treatment (n=5 mice). Also see Source Data . n, Survival curve of subcutaneous h lilrb4 -C1498-tumor-bearing mice (n=12 mice). Same as tumor size, anti-LILRB4 antibodies decreased the tumor weight ( o, n=5 mice) but did not in the absence of CD8 + T cells ( p, n=5 mice). The percentage of CD8 + T cells in spleen is significantly negatively correlated with tumor size ( q, n=5 mice) but not in the absence of CD8 + T cells ( r, n=5 mice). s, Adoptive transplantation of spleen cells from control mice or tumor-bearing mice that were cured by anti-LILRB4-N297A treatment (n=5 mice). Tumor size was monitored as a function of time. Arrow indicates day of rechallenge in mice that had eliminated leukemia with 3-times number of AML cells (n=4 mice). Also see Source Data . Anti-LILRB4 antibodies reduced the leukemia cells infiltrating into host tissues ( t-v, n=5 mice ) and even CD8 + cells were depleted ( w, n=5 mice). x-z, C57bl/6 mice were i.v. implanted with human LILRb4-expressing mouse AML C1498 cells (3×10 6 cells/mouse) that express GFP. Anti-LILRB4-N297A antibodies (n=9 mice) or control IgG (n=9 mice) were i.v. injected at 6, 9, 12, 15 and 18 days post implantation of tumor cells. Anti-LILRB4 antibodies decreased the percentage of leukemia cells in bone marrow ( x ). Anti-LILRB4 antibodies increased CD8 + T cells ( y ). The percentage of CD8 + T cells in bone marrow is significantly negatively correlated with the percentage of leukemia cells ( z ). ( c, i and l ) These experiments were repeated independently three times with similar results. See for definition of box plot elements in b, e, g-h, j-k, o-p and t-y . All p values (except of n from long-rank test; and except of q-r and z from Pearson’s correlation) were from two-tailed student t -test.

Journal: Nature

Article Title: LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration

doi: 10.1038/s41586-018-0615-z

Figure Lengend Snippet: a-c, WT or lilrb4 -KO THP-1 cells (3×10 6 cells/mouse) were subcutaneously implanted into hPBMC-repopulated NSG mice (WT, n=14 mice with mean and s.e.m.; lilrb4 -KO, n=10 mice with mean and s.e.m. Also see Source Data .). Shown are tumor size ( a ), quantitation of CD3 + at day 31 in peripheral blood of recipient mice ( b ) and representative flow plots showing CD4 + and CD8 + T cells ( c ). d-e, LILRB4 increases PD-1 expression on tumor-infiltrated T cells. WT or lilrb4 -KO THP-1 cells were subcutaneously implanted into hPBMC-repopulated NSG mice. Three weeks after implantation, 7 out of 10 WT-group mice had large tumors and 3 out of 10 KO-group mice had tiny tumors. These tumors were dissected for immunohistochemistry and flow cytometry staining with anti-LILRB4, anti-CD3, anti-PD-1 or anti-Arginase-1 antibodies. Left corner images were magnified from the yellow highlighted regions. In CD3 and PD-1 staining images, orange dash lines indicate the tumor boundary. Black arrowheads indicate PD-1 positive cells. Scale bar, 100 μm. Shown in e , tumors were dissected and cells in tumor region were stained with anti-CD3 and anti-PD-1 antibodies for flow cytometry analysis. The percentages of PD-1 + T cells (Ratio of PD-1 + CD3 + cells/CD3 + cells) were calculated. f-i, THP-1 cells were transplanted into hPBMC-repopulated NSG mice, and mice were treated with control IgG or anti-LILRB4 antibody after 6 days (10 mg/kg; n=5). Leukemia development was monitored by luminescence imaging ( f ); luminescence flux (radiance) at day 26 ( g ; n=5) and T cell numbers at day 26 in representative mice ( h-i ) were also shown. j-k, Engraftment of human T cells and i.v. transplanted Doxycycline (Dox)-inducible lilrb4 -knockout THP-1 cells (GFP + ) in NSG mice at day 7 before Dox administration (n=5). l, Representative flow plot shows LILRB4 was successfully deleted in engrafted leukemia cells in bone marrow of Dox-fed mouse at the endpoint. n.s., not significant. m-w, Mouse AML C1498 cells (3×10 6 cells/mouse) that stably express LILRB4-IRES-GFP were s.c. implanted into C57bl/6 mice. Anti-LILRB4-N297A antibodies or control IgG were i.v. injected at 6, 9, 12, 15, 18, and 21 days post implantation of tumor cells. Two groups of mice were treated with anti-CD8 antibodies at 3, 6, 9, and 12 days post implantation of tumor cells to achieve CD8 + T cell depletion. m, Tumor growth of subcutaneously implanted human LILRB4-expressing mouse AML C1498 cells (h lilrb4 -C1498) in C57BL/6 mice with anti-LILRB4-N297A antibody or control antibody treatment (n=5 mice). Also see Source Data . n, Survival curve of subcutaneous h lilrb4 -C1498-tumor-bearing mice (n=12 mice). Same as tumor size, anti-LILRB4 antibodies decreased the tumor weight ( o, n=5 mice) but did not in the absence of CD8 + T cells ( p, n=5 mice). The percentage of CD8 + T cells in spleen is significantly negatively correlated with tumor size ( q, n=5 mice) but not in the absence of CD8 + T cells ( r, n=5 mice). s, Adoptive transplantation of spleen cells from control mice or tumor-bearing mice that were cured by anti-LILRB4-N297A treatment (n=5 mice). Tumor size was monitored as a function of time. Arrow indicates day of rechallenge in mice that had eliminated leukemia with 3-times number of AML cells (n=4 mice). Also see Source Data . Anti-LILRB4 antibodies reduced the leukemia cells infiltrating into host tissues ( t-v, n=5 mice ) and even CD8 + cells were depleted ( w, n=5 mice). x-z, C57bl/6 mice were i.v. implanted with human LILRb4-expressing mouse AML C1498 cells (3×10 6 cells/mouse) that express GFP. Anti-LILRB4-N297A antibodies (n=9 mice) or control IgG (n=9 mice) were i.v. injected at 6, 9, 12, 15 and 18 days post implantation of tumor cells. Anti-LILRB4 antibodies decreased the percentage of leukemia cells in bone marrow ( x ). Anti-LILRB4 antibodies increased CD8 + T cells ( y ). The percentage of CD8 + T cells in bone marrow is significantly negatively correlated with the percentage of leukemia cells ( z ). ( c, i and l ) These experiments were repeated independently three times with similar results. See for definition of box plot elements in b, e, g-h, j-k, o-p and t-y . All p values (except of n from long-rank test; and except of q-r and z from Pearson’s correlation) were from two-tailed student t -test.

Article Snippet: The custom code for Pearson’s correlation analysis in RStudio is showed below.

Techniques: Quantitation Assay, Expressing, Immunohistochemistry, Flow Cytometry, Staining, Control, Imaging, Knock-Out, Stable Transfection, Injection, Transplantation Assay, Two Tailed Test